Elrefio subcutaneous injection 76mg, manufactured by Pfizer, contains Erlanatamab (genetical recombination). This bispecific antibody works by binding to CD3 on T-cells and a tumor-specific antigen, thereby redirecting T-cells to effectively eliminate cancer cells. It is supplied as 76mg in 1.9mL per bottle, with YJ code 4291470A2027.
Elrefio subcutaneous injection 76mg
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →